Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease

dc.contributor.authorMartínez Sanz, Javier
dc.contributor.authorTalavera Rodríguez, Alba
dc.contributor.authorDíaz Álvarez, Jorge
dc.contributor.authorRosas Cancio-Suárez, Marta
dc.contributor.authorRodríguez Gómez, Juan Miguel
dc.contributor.authorAlba Rubio, Claudio
dc.contributor.authorMontes, María Luisa
dc.contributor.authorMartín Mateos, Rosa
dc.contributor.authorBurgos Santamaría, Diego
dc.contributor.authorMoreno, Santiago
dc.contributor.authorSerrano Villar, Sergio
dc.contributor.authorSánchez Conde, Matilde
dc.date.accessioned2024-04-30T14:54:50Z
dc.date.available2024-04-30T14:54:50Z
dc.date.issued2023-12-14
dc.descriptionAuthor contributions: JM: Formal Analysis, Investigation, Software, Writing – original draft. AT: Formal Analysis, Investigation, Writing – original draft. JD: Supervision, Writing – review & editing. MC: Writing – review & editing. JR: Formal Analysis, Methodology, Software, Writing – review & editing. CA: Investigation, Writing – review & editing. MM: Writing – review & editing. RM: Writing – review & editing. DB: Writing – review & editing. SM: Writing – review & editing. SS: Conceptualization, Methodology, Validation, Writing – review & editing. MS: Conceptualization, Formal Analysis, Investigation, Methodology, Resources, Supervision, Writing – original draft, Writing – review & editing.
dc.description.abstractIntroduction: Metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as an increasingly recognized problem among people living with HIV (PLWH). The gut-liver axis is considered to be strongly implicated in the pathogenesis of MASLD. We aimed to characterize the gut microbiota composition in PLWH and MASLD and compare it with that of two control groups: PLWH without MASLD and individuals with MASLD without HIV infection. Methods: We collected clinical data and stool samples from participants. Bacterial 16S rRNA genes were amplified, sequenced, and clustered into operational taxonomic unit. Alpha diversity was studied by Shannon and Simpson indexes. To study how different the gut microbiota composition is between the different groups, beta diversity estimation was evaluated by principal coordinate analysis (PCoA) using Bray-Curtis dissimilarity. To further analyze differences in microbiome composition we performed a linear discriminant analysis (LDA) effect size (LEfSe). Results: We included 30 HIV+MASLD+, 30 HIV+MASLD- and 20 HIV-MASLD+ participants. Major butyrate producers, including Faecalibacterium, Ruminococcus, and Lachnospira dominated the microbiota in all three groups. Shannon’s and Simpson’s diversity metrics were higher among MASLD+ individuals (Kruskal-Wallis p = 0.047). Beta diversity analysis showed distinct clustering in MASLD-, with MASLD+ participants overlapping regardless of HIV status (ADONIS significance <0.001). MASLD was associated with increased homogeneity across individuals, in contrast to that observed in the HIV+NAFDL- group, in which the dispersion was higher (Permanova test, p value <0.001; ANOSIM, p value <0.001). MASLD but not HIV determined a different microbiota structure (HIV+MASLD- vs. HIV+MASLD+, q-value = 0.002; HIV-MASLD+ vs. HIV+MASLD+, q-value = 0.930; and HIV-MASLD+ vs. HIV+MASLD-, q-value < 0.001). The most abundant genera in MASLD- were Prevotella, Bacteroides, Dialister, Acidaminococcos, Alloprevotella, and Catenibacterium. In contrast, the most enriched genera in MASLD+ were Ruminococcus, Streptococcus, Holdemanella, Blautia, and Lactobacillus. Conclusions: We found a microbiome signature linked to MASLD, which had a greater influence on the overall structure of the gut microbiota than HIV status alone.
dc.description.departmentSección Dptal. de Nutrición y Ciencia de los Alimentos (Veterinaria)
dc.description.facultyFac. de Veterinaria
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades (España)
dc.description.statuspub
dc.identifier.citationMartínez-Sanz J, Talavera-Rodríguez A, Díaz-Álvarez J, Rosas Cancio-Suárez M, Rodríguez JM, Alba C, Montes ML, Martín-Mateos R, Burgos-Santamaría D, Moreno S, Serrano-Villar S and Sánchez Conde M (2023) A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease. Front. Immunol. 14:1297378. doi: 10.3389/fimmu.2023.1297378
dc.identifier.doi10.3389/fimmu.2023.1297378
dc.identifier.issn1664-3224
dc.identifier.officialurlhttps://doi.org/10.3389/fimmu.2023.1297378
dc.identifier.urihttps://hdl.handle.net/20.500.14352/103711
dc.issue.number1297378
dc.journal.titleFrontiers in Immunology
dc.language.isoeng
dc.publisherFrontiers
dc.relation.projectIDinfo:eu-repo/grantAgreement/MCIU/PEICTI2013-2016/PI17-01717
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu612.017
dc.subject.keywordHIV
dc.subject.keywordMASLD
dc.subject.keywordNAFLD
dc.subject.keywordGut microbiome
dc.subject.keywordMicrobiome
dc.subject.ucmVeterinaria
dc.subject.unesco3109 Ciencias Veterinarias
dc.titleA gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number14
dspace.entity.typePublication
relation.isAuthorOfPublication5a0ccdac-6fa4-40c7-8e77-082364812226
relation.isAuthorOfPublication751dc85d-cdd9-4064-82c1-ccee5dfcbe16
relation.isAuthorOfPublication.latestForDiscovery5a0ccdac-6fa4-40c7-8e77-082364812226

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fimmu-14-1297378.pdf
Size:
2.33 MB
Format:
Adobe Portable Document Format
Description:
A gut microbiome signature for HIV and metabolic dysfunction-associated steatotic liver disease

Collections